Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents Valentin al JalaliMarkus Zeitlinger Review Article Open access 26 February 2020 Pages: 827 - 847
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib Dominique LevêqueGuillaume BeckerShanti Natarajan-Amé Review Article 29 February 2020 Pages: 849 - 856
Pharmacokinetic Variability of Therapeutic Antibodies in Humans: A Comprehensive Review of Population Pharmacokinetic Modeling Publications Amina BensalemDavid Ternant Review Article 13 March 2020 Pages: 857 - 874
Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients with Solid Tumors Aurelia H. M. de Vries SchultinkKees BolAlwin D. R. Huitema Original Research Article 31 January 2020 Pages: 875 - 884
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate Femke de VeldeBrenda C. M. de WinterCOMBACTE-NET consortium Original Research Article Open access 20 January 2020 Pages: 885 - 898
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis Ruben van der GaliënNatasha van’t Boveneind-VrubleuskayaJan-Willem C. Alffenaar Original Research Article 25 January 2020 Pages: 899 - 910
Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus Paola MianKarel AllegaertAndré Dallmann Original Research Article Open access 12 February 2020 Pages: 911 - 925
Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial Manuela VayMarleen Julia MeyerGerd Mikus Original Research Article Open access 15 February 2020 Pages: 927 - 939
Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients Stefanie L. GroenlandRuben A. G. van EerdenThe Dutch Pharmacology Oncology Group (DPOG) Original Research Article 04 February 2020 Pages: 941 - 948
